麦克奥迪（厦门）电气股份有限公司 2020 年半年度报告全文 麦克奥迪（厦门）电气股份有限公司 2020 年半年度报告 2020-060 2020 年 08 月 1 麦克奥迪（厦门）电气股份有限公司 2020 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的 真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别 和连带的法律责任。 公司负责人杨泽声、主管会计工作负责人胡春华及会计机构负责人(会计主 管人员)蔡亮声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本报告中所涉及的未来经营计划或规划等前瞻性陈述的，均不构成公司对 任何投资者及相关人士的实质承诺，投资者及相关人士均应对此保持足够的风 险认识，并且应当理解计划、预测与承诺之间的差异。 公司在本半年度报告第四节"经营情况讨论与分析"之"九、公司面临的风险 和应对措施"中描述了公司经营中可能存在的风险及应对措施，敬请投资者注意 并仔细阅读。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 2 麦克奥迪（厦门）电气股份有限公 ...

麦克奥迪（厦门）电气股份有限公司 2020 年第一季度报告全文 麦克奥迪（厦门）电气股份有限公司 2020 年第一季度报告 2020-035 2020 年 04 月 1 麦克奥迪（厦门）电气股份有限公司 2020 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人杨泽声、主管会计工作负责人胡春华及会计机构负责人(会计主 管人员)蔡亮声明：保证季度报告中财务报表的真实、准确、完整。 2 麦克奥迪（厦门）电气股份有限公司 2020 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业总收入（元） | 192,810,014.69 | 221,000,338.38 | -12.76% | | 归属于上市公司股东的净利润（元） ...

Financial Performance - The company reported a revenue of approximately 510 million RMB for the year 2019, with a cash dividend of 0.3 RMB per 10 shares distributed to shareholders[10]. - The company's total revenue for 2019 was approximately ¥1.12 billion, representing a year-over-year increase of 14.23% compared to ¥978.8 million in 2018[21]. - Net profit attributable to shareholders for 2019 was approximately ¥148.3 million, a slight increase of 0.36% from ¥147.8 million in 2018[21]. - The net profit after deducting non-recurring gains and losses was approximately ¥139.9 million, reflecting a 2.02% increase from ¥137.1 million in 2018[21]. - The company's operating cash flow for 2019 was approximately ¥169.8 million, which is a 9.60% increase compared to ¥155.0 million in 2018[21]. - The total profit amounted to 188.00 million yuan, representing a year-on-year growth of 4.36%[32]. - Net profit attributable to shareholders was 148.31 million yuan, with a slight increase of 0.36% year-on-year[32]. - The company achieved total revenue of 1,118.09 million yuan, a year-on-year increase of 14.23%[58]. - The cash dividend proposed is ¥0.3 per 10 shares, totaling ¥15,304,900.08, which represents 10.81% of the distributable profit for 2019[122][124]. Business Segments and Operations - The company has established four main business segments: Big Data and AI Medical, Optoelectronics, Intelligent Electrical, and Smart Energy Technology, following previous mergers and acquisitions[7]. - The company operates in four main business segments: big data and AI medical business, optoelectronics, energy technology, and smart electrical business[30]. - The smart energy technology segment focuses on energy management platform operations and comprehensive energy service operations, aiming to improve energy efficiency and reduce costs for enterprises[31]. - The company has established a nationwide tumor precision diagnosis service network through digital pathology remote diagnosis and quality control platforms[30]. - The company is actively developing a range of new products and services in big data and AI medical sectors, focusing on early tumor screening[35]. - The company has established a remote digital pathology consultation platform covering over 1,300 hospitals nationwide, enhancing its capabilities in cancer diagnosis and treatment[48]. - The company is exploring e-commerce sales channels, having entered platforms like Amazon, eBay, and Tmall, which may become a new growth point[39]. - The company has established a new smart energy technology business that provides comprehensive energy management services to reduce energy costs and improve efficiency for enterprise users[60]. Market and Economic Environment - Foreign market sales accounted for about 50% of the company's total revenue, indicating significant exposure to currency fluctuation risks[9]. - The company acknowledges the operational management risks associated with integrating its various business segments and the need for enhanced asset control and financial management[7]. - The company is aware of the uncertainties posed by macroeconomic changes, particularly due to the COVID-19 pandemic, which may require adjustments in its business strategies[5]. - The growth was driven by external policy factors, including the promotion of new infrastructure construction related to 5G and smart cities[32]. - The company recognizes the risks posed by macroeconomic changes and the need to adapt its business model in response to evolving market conditions[113]. Research and Development - The company emphasizes the importance of innovation and timely product development in response to market demand, highlighting the ongoing risk associated with technology updates and product development[8]. - The company has established two academician expert workstations to enhance internal technological and integrated innovation[33]. - The company has obtained 8 invention patents, 6 utility models, and 13 software copyrights, showcasing its commitment to innovation in the AI medical field[48]. - The company is committed to maintaining a high-quality professional team by attracting top talent and fostering a culture of shared success[62]. - The company emphasizes R&D as a core competitive advantage, optimizing processes to ensure seamless integration between R&D, marketing, and sales departments[61]. Governance and Compliance - The company’s financial report has been confirmed as accurate and complete by its board of directors and senior management, ensuring accountability[3]. - The company has established a governance structure to enhance management effectiveness and internal controls[115]. - The company has not engaged in any related party transactions during the reporting period, ensuring transparency in operations[147]. - The company maintains a structured approach to governance and oversight through its board and management team[189]. - The company has a complete and independent business system for research, development, production, and sales[198]. Human Resources and Management - The company is enhancing its human resources management by establishing a competitive incentive system and focusing on training to improve employee skills and stability[62]. - The total number of employees is 2,206, with 577 in the parent company and 1,629 in major subsidiaries[190]. - Employee composition includes 1,227 production personnel, 178 sales personnel, 398 technical personnel, 60 financial personnel, 177 administrative personnel, and 166 others[190]. - The company emphasizes a fair and competitive compensation system to align employee interests with company performance[191]. - The management team has extensive experience in their respective fields, contributing to strategic decision-making[182]. Strategic Goals and Future Plans - The company aims to expand its business in line with national industrial policies, particularly in areas such as 5G infrastructure and industrial internet, to leverage opportunities arising from the current economic climate[5]. - The company plans to leverage its technology advantages in new infrastructure projects, particularly in areas like medical big data, artificial intelligence, and industrial internet, to drive future growth[109]. - The company intends to utilize the capital market for refinancing to strengthen its financial position and support business expansion[111]. - The company aims to optimize its management structure by dividing into four business units: big data medical, optoelectronics, smart electrical, and smart energy technology, enhancing operational efficiency[108]. - The company is focused on maintaining its market position and exploring new opportunities for growth through strategic partnerships[182].

麦克奥迪（厦门）电气股份有限公司 2019 年第三季度报告全文 麦克奥迪（厦门）电气股份有限公司 2019 年第三季度报告 2019-046 2019 年 10 月 1 麦克奥迪（厦门）电气股份有限公司 2019 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人杨泽声、主管会计工作负责人胡春华及会计机构负责人(会计主 管人员)蔡亮声明：保证季度报告中财务报表的真实、准确、完整。 2 麦克奥迪（厦门）电气股份有限公司 2019 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产（元） | 1,594,834,093.81 | | 1,438,161,162.39 | 10.89% | | 归属于 ...

Financial Performance - The total revenue for the reporting period was ¥482,499,222.60, representing a year-on-year increase of 13.46% compared to ¥425,261,940.98 in the same period last year[22]. - The net profit attributable to shareholders of the listed company was ¥51,568,565.10, an increase of 8.68% from ¥47,448,728.32 in the previous year[22]. - The net profit after deducting non-recurring gains and losses was ¥48,555,827.54, reflecting a growth of 12.36% compared to ¥43,216,294.13 in the same period last year[22]. - The total profit reached 63.95 million yuan, up 9.19% compared to the same period last year[53]. - The company reported a net profit for the first half of 2019 of ¥44.45 million, compared to ¥51.79 million in the first half of 2018, indicating a decrease of approximately 14.14%[151]. - The total comprehensive income for the first half of 2019 was ¥44.45 million, compared to ¥51.79 million in the first half of 2018, reflecting a decrease of approximately 14.14%[151]. Business Segments and Operations - The company has established four business segments: "Big Data and AI Medical Business," "Optoelectronic Business," "Smart Energy Technology Business," and "Intelligent Electrical Business," which require enhanced management capabilities[6]. - The company operates in four main business segments: Big Data and AI Medical Business, Optoelectronics, Energy Technology, and Smart Electrical Business, focusing on integrated solutions and innovative products[29][30][31]. - The company is focusing on three core business areas: third-party pathology testing services, automated tumor cell screening systems, and AI-assisted diagnostic systems[39]. - The company has developed a comprehensive tumor precision diagnosis service network, integrating online and offline services to enhance its market position in the healthcare sector[29][31]. - The company is expanding its smart energy technology business to provide energy management services through its software platform[38]. Innovation and R&D - The company emphasizes the importance of innovation and continuous product development to maintain market competitiveness[7]. - The company has established two academician expert workstations to drive technological and integrated innovation, enhancing product development across its business segments[33]. - The company has obtained 9 invention patents, 6 utility model patents, and 11 software copyrights related to AI products, reflecting its ongoing innovation efforts[45]. - The company is focusing on AI-assisted diagnostic products, which have become a new highlight of its business[52]. - The AI-assisted diagnostic system has launched products for malaria detection, tuberculosis screening, and oral cancer screening, aiming to improve healthcare service levels[34]. Financial Management and Risks - The company plans to not distribute cash dividends or issue bonus shares, indicating a focus on reinvestment[9]. - The company faces risks related to technological updates and product development, which could impact its market position if not managed effectively[7]. - The company has a commitment to adapt to regulatory changes in the industry to mitigate operational risks[5]. - The company will implement measures to mitigate risks from currency fluctuations by using hedging tools and adjusting contracts with clients[88]. - The company has a proactive approach to managing operational risks by strengthening internal controls and governance structures[86]. Market Presence and Sales - Approximately 50% of the company's sales revenue comes from international markets, making it susceptible to foreign exchange fluctuations[88]. - The sales model includes direct sales and distribution, with a focus on the education and biomedical markets[36]. - The company has developed the "Motic EasyScan Go," the world's first AI microscope for malaria detection, in collaboration with the Bill and Melinda Gates Foundation[34]. - The smart energy management platform has registered 1,300 users and provided 151 energy efficiency analysis reports, showcasing the company's commitment to energy internet construction[47]. Legal and Compliance - The company’s financial report is guaranteed to be true, accurate, and complete by its management, ensuring accountability[3]. - The company is committed to complying with the disclosure requirements for medical device businesses as per the Shenzhen Stock Exchange guidelines[58]. - The company is involved in a significant arbitration case with a supplier, involving a disputed amount of 64.205 million yuan related to accounts receivable[97]. - The company has initiated legal proceedings to revoke the arbitration and has submitted the case to the Shenzhen Intermediate People's Court for review[99]. Shareholder Information - There were no significant changes in shareholding structure, with total shares remaining at 510,163,336[117]. - The largest shareholder, MacAudie Holdings Limited, held 40.96% of shares, totaling 208,762,140 shares[120]. - The total number of ordinary shareholders at the end of the reporting period was 13,908[119]. - The company did not engage in any major related party transactions during the reporting period[102]. Asset and Liability Management - The total assets at the end of the reporting period were ¥1,489,181,870.62, which is a 3.55% increase from ¥1,438,161,162.39 at the end of the previous year[22]. - The total liabilities amounted to CNY 526,431,377.33, slightly up from CNY 522,851,459.54 at the end of 2018[137]. - The company's total liabilities to equity ratio was approximately 0.55, indicating a stable leverage position[137]. - Cash and cash equivalents at the end of the reporting period were CNY 410,222,835.20, a decrease of 5.19% from CNY 470,871,084.52 in the previous year[71].

麦克奥迪（厦门）电气股份有限公司 2019 年第一季度报告全文 麦克奥迪（厦门）电气股份有限公司 2019 年第一季度报告 2019-025 2019 年 04 月 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 1 麦克奥迪（厦门）电气股份有限公司 2019 年第一季度报告全文 公司负责人杨泽声、主管会计工作负责人胡春华及会计机构负责人(会计主 管人员)郭春碧声明：保证季度报告中财务报表的真实、准确、完整。 2 麦克奥迪（厦门）电气股份有限公司 2019 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 √ 是 □ 否 追溯调整或重述原因 同一控制下企业合并 | | 本报告期 | 上年同期 | | 本报告期比上年同 | | --- | --- | --- | --- | --- | | | | | | 期增减 | | | | 调整前 | 调整后 | 调整后 | | 营业总收入（元 ...

Financial Performance - The company achieved a revenue of 510,163,336 RMB for the year 2018, with a cash dividend of 0.58 RMB per 10 shares proposed for distribution to shareholders [11]. - The company's operating revenue for 2018 was approximately ¥978.8 million, representing a year-over-year increase of 13.30% compared to ¥863.9 million in 2017 [22]. - Net profit attributable to shareholders for 2018 was approximately ¥147.8 million, reflecting a growth of 9.32% from ¥135.2 million in 2017 [22]. - The total assets at the end of 2018 amounted to approximately ¥1.44 billion, a 1.99% increase from ¥1.41 billion at the end of 2017 [22]. - The net assets attributable to shareholders decreased by 20.98% to approximately ¥864.9 million from ¥1.09 billion in 2017 [22]. - The company reported a net cash flow from operating activities of approximately ¥155.0 million, down 8.51% from ¥169.4 million in 2017 [22]. - The total profit reached 180.15 million yuan, growing by 13.66% compared to the previous year [36]. - The company achieved total revenue of RMB 97,879.99 million, representing a year-on-year growth of 13.30% [62]. - Net profit attributable to shareholders was RMB 14,777.07 million, reflecting a year-on-year growth of 9.32% [62]. - The company reported a revenue of 140,482,598 RMB from its medical diagnostics segment, contributing to a net profit of 23,547,411.7 RMB [117]. Business Segments - The company operates four business segments: optical business, medical business, electrical business, and energy business, which require enhanced management capabilities [6]. - The company operates in four business segments: optical business, medical business, electrical business, and smart energy business [32]. - The optical business focuses on the development and sales of optical microscopes and digital imaging systems, targeting education, scientific research, and biomedical fields [33]. - The medical business provides integrated systems for tumor pathology diagnosis and personalized precision medicine, leveraging big data and AI for diagnostic support [34]. - The company is focusing on smart energy management and comprehensive energy services, enhancing energy efficiency and reducing costs for clients [36]. - The revenue from medical diagnostic products and services reached ¥140.2 million, a significant increase of 58.03% compared to ¥88.7 million in 2017 [77]. - The revenue from the electrical products segment was approximately ¥433.2 million, accounting for 44.26% of total revenue, with a growth of 9.70% year-on-year [76]. - The microscope manufacturing segment generated approximately ¥405.4 million, representing 41.42% of total revenue, with a year-on-year increase of 6.61% [76]. Acquisitions and Mergers - The company has expanded its business through acquisitions, including the cash acquisition of Motic Medical, which is expected to lead to further mergers and acquisitions [8]. - The company completed the acquisition of 80% of Medi Medical, making it a wholly-owned subsidiary, which has become a significant part of the company's operations [37]. - The company acquired 100% equity of Gelpag Advanced Technology GmbH for ¥2,934,870.80 on March 28, 2018 [84]. - The company acquired 100% of 麦克奥迪（厦门）医疗诊断系统有限公司 on June 8, 2018, which is expected to positively impact overall performance [117]. - The acquisition of 80% equity in Maidi Medical Diagnostic Systems Co., Ltd. was expected to yield CNY 15 million, with actual performance at CNY 23.38 million, also surpassing forecasts [149]. Innovation and R&D - The company emphasizes innovation and self-research as key development paths, facing risks related to technology updates and product development [9]. - The company’s commitment to continuous product and technology innovation is crucial for maintaining market competitiveness [9]. - The company is focusing on developing AI-assisted diagnostic systems to improve accuracy and reduce workload for pathologists [48]. - The company is integrating new technologies and materials into its products to enhance their technological value and maintain market competitiveness [37]. - The company has established partnerships with several universities and research institutions, enhancing its R&D capabilities and accelerating product updates [92]. - The R&D investment for 2018 amounted to approximately ¥57.33 million, representing 5.86% of the operating revenue, an increase from 5.27% in 2017 [95]. - The company has launched new medical products, including a series of digital slice scanners and intelligent microscopes, to meet market demands [94]. Market Exposure and Risks - Approximately 50% of the company's total revenue comes from overseas markets, indicating significant exposure to foreign exchange risks [10]. - The company’s financial performance may be adversely affected by fluctuations in exchange rates between the RMB and foreign currencies [10]. - The macroeconomic environment remains complex, with risks associated with economic transformation and structural adjustments impacting industry market capacity [5]. - The company is subject to operational management risks due to the complexity of its diversified business model [7]. - The company aims to address potential risks from national policy adjustments and macroeconomic changes by closely monitoring policy shifts and leveraging its business cycle differences [127]. Corporate Governance and Management - The company has established a robust internal management and control system to enhance corporate governance and protect shareholder rights [182]. - A scientific and standardized incentive system is being established to optimize human resource management and attract high-quality talent [67]. - The company is committed to strengthening its management structure and internal controls to address operational risks associated with its expanded business model [128]. - The company emphasizes the importance of fine management to improve operational efficiency and adapt to market changes [124]. Shareholder Information and Dividends - The company has a cash dividend policy that mandates at least 20% of the annual distributable profit to be distributed as cash dividends [135]. - The total cash dividend for the reporting period amounted to approximately ¥29.59 million, representing 100% of the profit distribution total [137]. - The cash dividend per 10 shares is ¥0.58, with a total of 510,163,336 shares as the basis for distribution [136]. - The company has maintained a consistent dividend payout ratio over the past three years, with 20.76% in 2017 and 18.43% in 2016 [145]. - The company’s remaining undistributed profits will be reserved for future distribution [140]. Social Responsibility - The company actively participated in social responsibility initiatives, including donations for medical equipment in impoverished areas [183]. - The company plans to continue its commitment to poverty alleviation through capital and social support initiatives in the future [185].

Financial Performance - Operating revenue for the reporting period was ¥267,651,176.18, representing a year-on-year increase of 23.93%[7] - Net profit attributable to shareholders increased by 38.83% to ¥47,792,304.06 for the reporting period[7] - Basic earnings per share rose by 38.20% to ¥0.0937[7] - The weighted average return on net assets was 4.99%, an increase of 1.58% compared to the same period last year[7] - The company reported a significant increase in revenue for Q3 2018, with a year-over-year growth of 25%[22] - Net profit for Q3 2018 was ¥48,515,963.68, representing a growth of 38.06% from ¥35,117,782.99 in Q3 2017[43] - The company achieved an operating profit of ¥57,214,579.19, which is a 38.76% increase from ¥41,247,182.50 in the previous year[43] - Total operating revenue for the current period reached ¥692,913,117.16, an increase of 13.6% compared to ¥609,653,998.46 in the previous period[50] - Net profit for the current period was ¥95,943,863.36, representing a 6.5% increase from ¥90,545,983.58 in the previous period[51] Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,431,294,861.65, an increase of 1.51% compared to the end of the previous year[7] - Net assets attributable to shareholders decreased by 25.46% to ¥818,247,762.54 compared to the end of the previous year[7] - The company's total assets increased significantly, with construction in progress rising by 1280.48% to 2,379.13 million CNY compared to December 31, 2017[18] - Total liabilities increased significantly to CNY 563,781,984.45 from CNY 205,851,160.59, marking a rise of approximately 173.5%[36] - The company's equity attributable to shareholders decreased to CNY 818,247,762.54 from CNY 1,097,790,295.77, a decline of about 25.5%[36] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥86,461,046.67, a decrease of 20.47% compared to the same period last year[7] - The total cash inflow from operating activities was CNY 704,586,422.94, an increase of 9.34% compared to CNY 644,437,381.77 in the previous period[56] - The net cash flow from operating activities decreased to CNY 86,461,046.67, down 20.43% from CNY 108,708,517.81 in the previous period[56] - The cash inflow from financing activities was CNY 228,525,000.00, up from CNY 72,600,000.00 in the previous period, reflecting a strong increase in financing[58] - The net cash flow from financing activities increased to CNY 168,376,622.50, compared to CNY 47,016,688.24 in the previous period, showing improved financing conditions[58] Shareholder Information - The company reported a total of 18,203 common shareholders at the end of the reporting period[11] - The top shareholder, MacAudie Holdings Limited, holds 40.92% of the shares, totaling 208,762,140 shares[11] - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[12] Investment and Expenses - The company's financial expenses for the first nine months of 2018 were -565.68 million CNY, an increase of 536.18% year-on-year, primarily due to increased foreign exchange gains from the appreciation of the US dollar[19] - Investment income decreased by 423.63% year-on-year to -199.43 million CNY, mainly due to losses from foreign exchange forward contracts[19] - Research and development expenses increased to ¥15,885,551.02, up 25.00% from ¥12,624,825.11 in the same quarter last year[41] - Research and development expenses increased to ¥34,387,938.14, up 21.8% from ¥28,241,199.83 in the prior period[50] Market Outlook and Strategy - The company provided a positive outlook for the next quarter, projecting a revenue increase of 20% based on current market trends[24] - New product development is underway, with two innovative products expected to launch in Q4 2018, targeting a market share increase of 10%[25] - The company is expanding its market presence in Southeast Asia, aiming for a 30% increase in sales in that region by the end of 2019[26] - A strategic acquisition of a local competitor is in progress, which is anticipated to enhance the company's product offerings and customer base[27] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[41] Compliance and Governance - There were no violations regarding external guarantees during the reporting period, ensuring financial stability[27] - The company has no non-operating fund occupation by controlling shareholders or related parties during the reporting period[29] - The management emphasized the importance of adhering to non-competition agreements to avoid conflicts with existing business operations[23]

麦克奥迪（厦门）电气股份有限公司 2018 年半年度报告全文 麦克奥迪（厦门）电气股份有限公司 2018 年半年度报告 2018-045 2018 年 08 月 1 麦克奥迪（厦门）电气股份有限公司 2018 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的 真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别 和连带的法律责任。 公司负责人杨泽声、主管会计工作负责人胡春华及会计机构负责人(会计主 管人员)郭春碧声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本公司请投资者认真阅读本半年度报告全文，并特别注意公司面临的风险 因素，详见本报告第四节"经营情况讨论与分析"之"十、公司面临的风险和应对 措施"部分。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 2 | 第一节 重要提示、目录和释义 2 | | --- | | 第二节 公司简介和主要财务指标 5 | | 第三节 公司业务概要 8 | | 第四节 经营情况讨论与分析 14 | | 第五节 重要事项 26 | | 第 ...

2018 年 04 月 1 麦克奥迪（厦门）电气股份有限公司 2018 年第一季度报告全文 麦克奥迪（厦门）电气股份有限公司 2018 年第一季度报告 2018-031 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 麦克奥迪（厦门）电气股份有限公司 2018 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人杨泽声、主管会计工作负责人胡春华及会计机构负责人(会计主 管人员)郭春碧声明：保证季度报告中财务报表的真实、准确、完整。 2 麦克奥迪（厦门）电气股份有限公司 2018 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 3 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业总收入（元） | 165,310,494.35 | 166,051,265.79 | -0.45% | | 归属于上市公司股东的净利润（ ...